Skip to main content
TipRanks
Go Ultimate75% OFF

Ann Clare Kessler Insider Profile

4 Followers

Ann Clare Kessler, Director at Epigenomics, holds 137.60K shares in Epigenomics (Ticker: GB:0QXH). Most recently, Ann Clare Kessler Bought 22,200 shares of Epigenomics on Oct 26, 2020 for an estimated value of €19.88K.

Ann Clare Kessler's Trading History

0QXH
Epigenomics
Oct 26, 2020DirectorInformative Buy19.88K€125.91K
GB:0QXH
Insider Shares: 137.60K (31.61%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 26, 2020Informative Buy$19.88K22,200$0.90-93.40%―
Nov 13, 2019Informative Buy€35.24K31,752€1.11-54.00%―
Jun 03, 2019Informative Buy$39.90K18,002$2.22-44.50%―
Apr 03, 2019Informative Buy$49.99K24,851$2.01-38.00%―
Oct 26, 2018Informative Buy€50.86K27,345€1.86-30.40%―

You May Also Like

Ann Clare Kessler insider profile FAQ

What is the percentage of profitable transactions made by Ann Clare Kessler?
The percentage of profitable transactions made by Ann Clare Kessler is 30%.
What is the average return per transaction made by Ann Clare Kessler?
The average return per transaction made by Ann Clare Kessler is -19.30%.
What stocks does Ann Clare Kessler hold?
Ann Clare Kessler holds: GB:0QXH stocks.
What was Ann Clare Kessler’s latest transaction?
Ann Clare Kessler’s latest transaction was an Informative Buy of €19.88K.
What was Ann Clare Kessler's most profitable transaction?
Ann Clare Kessler’s most profitable transaction was an Informative Buy of GB:0QXH stock on August 15, 2016. The return on the trade was 42.30%.
What is Ann Clare Kessler's role in Epigenomics?
Ann Clare Kessler's role in Epigenomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.